ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...

Full year 2025 financial guidance excludes any potential ... and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which ...

TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.

In a ”Worker Adjustment & Retraining Notification Notices” (WARN) report issued by the Texas Workforce Commission, it states ...

Full year 2025 financial guidance excludes any potential share repurchase or additional M&A activity. CEO Dr. Steve Cutler commented, "ICON continues to navigate dynamic clinical development ...